These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38398156)

  • 1. Focal Minimally Invasive Treatment in Localized Prostate Cancer: Comprehensive Review of Different Possible Strategies.
    Faiella E; Santucci D; D'Amone G; Cirimele V; Vertulli D; Bruno A; Beomonte Zobel B; Grasso RF
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement.
    Deivasigamani S; Kotamarti S; Rastinehad AR; Salas RS; de la Rosette JJMCH; Lepor H; Pinto P; Ahmed HU; Gill I; Klotz L; Taneja SS; Emberton M; Lawrentschuk N; Wysock J; Feller JF; Crouzet S; Kumar M P; Seguier D; Adams ES; Michael Z; Abreu A; Jack Tay K; Ward JF; Shinohara K; Katz AE; Villers A; Chin JL; Stricker PD; Baco E; Macek P; Ahmad AE; Chiu PKF; Crawford ED; Rogers CG; Futterer JJ; Rais-Bahrami S; Robertson CN; Hadaschik B; Marra G; Valerio M; Chong KT; Kasivisvanathan V; Tan WP; Lomas D; Walz J; Guimaraes GC; Mertziotis NI; Becher E; Finelli A; Kasraeian A; Lebastchi AH; Vora A; Rosen MA; Bakir B; Arcot R; Yee S; Netsch C; Meng X; de Reijke TM; Tan YG; Regusci S; Benjamin TGR; Olivares R; Noureldin M; Bianco FJ; Sivaraman A; Kim FJ; Given RW; Dason S; Sheetz TJ; Shoji S; Schulman A; Royce P; Shah TT; Scionti S; Salomon G; Laguna P; Tourinho-Barbosa R; Aminsharifi A; Cathelineau X; Gontero P; Stabile A; Grummet J; Ledbetter L; Graton M; Stephen Jones J; Polascik TJ;
    Eur Urol; 2023 Dec; 84(6):547-560. PubMed ID: 37419773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years?
    Hopstaken JS; Bomers JGR; Sedelaar MJP; Valerio M; Fütterer JJ; Rovers MM
    Eur Urol; 2022 Jan; 81(1):5-33. PubMed ID: 34489140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Focal vs Extended Irreversible Electroporation for the Ablation of Localized Low- or Intermediate-Risk Prostate Cancer on Early Oncological Control: A Randomized Clinical Trial.
    Zhang K; Teoh J; Laguna P; Dominguez-Escrig J; Barret E; Ramon-Borja JC; Muir G; Bohr J; de Reijke TM; Pelechano Gómez P; Ng CF; Sanchez-Salas R; de la Rosette J
    JAMA Surg; 2023 Apr; 158(4):343-349. PubMed ID: 36723911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncological results and cancer control definition in focal therapy for Prostate Cancer: a systematic review.
    Nicoletti R; Alberti A; Castellani D; Yee CH; Zhang K; Poon DMC; Chiu PK; Campi R; Resta GR; Dibilio E; Pirola GM; Chiacchio G; Fuligni D; Brocca C; Giulioni C; De Stefano V; Serni S; Gauhar V; Ng CF; Gacci M; Teoh JYC
    Prostate Cancer Prostatic Dis; 2023 Jul; ():. PubMed ID: 37507479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort.
    Blazevski A; Scheltema MJ; Yuen B; Masand N; Nguyen TV; Delprado W; Shnier R; Haynes AM; Cusick T; Thompson J; Stricker P
    Eur Urol Oncol; 2020 Jun; 3(3):283-290. PubMed ID: 31103721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer.
    Scheltema MJ; van den Bos W; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD
    BJU Int; 2017 Nov; 120 Suppl 3():51-58. PubMed ID: 28834167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial.
    Scheltema MJ; van den Bos W; de Bruin DM; Wijkstra H; Laguna MP; de Reijke TM; de la Rosette JJ
    BMC Cancer; 2016 May; 16():299. PubMed ID: 27150293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.
    Valerio M; Cerantola Y; Eggener SE; Lepor H; Polascik TJ; Villers A; Emberton M
    Eur Urol; 2017 Jan; 71(1):17-34. PubMed ID: 27595377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New technologies and techniques for prostate cancer focal therapy.
    Linares-Espinós E; Carneiro A; Martínez-Salamanca JI; Bianco F; Castro-Alfaro A; Cathelineau X; Valerio M; Sanchez-Salas R
    Minerva Urol Nefrol; 2018 Jun; 70(3):252-263. PubMed ID: 29664243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal irreversible electroporation as primary treatment for localized prostate cancer.
    van den Bos W; Scheltema MJ; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD
    BJU Int; 2018 May; 121(5):716-724. PubMed ID: 28796935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional outcomes and safety of focal therapy for prostate cancer: a systematic review on results and patient-reported outcome measures (PROMs).
    Nicoletti R; Alberti A; Castellani D; Yee CH; Zhang K; Poon DMC; Chiu PK; Campi R; Resta GR; Dibilio E; Pirola GM; Chiacchio G; Fuligni D; Brocca C; Giulioni C; De Stefano V; Serni S; Gauhar V; Ng CF; Gacci M; Teoh JYC
    Prostate Cancer Prostatic Dis; 2023 Jul; ():. PubMed ID: 37491432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multicenter, Randomized, Single-blind, 2-Arm Intervention Study Evaluating the Adverse Events and Quality of Life After Irreversible Electroporation for the Ablation of Localized Low-intermediate Risk Prostate Cancer.
    de la Rosette J; Dominguez-Escrig J; Zhang K; Teoh J; Barret E; Ramon-Borja JC; Muir G; Bohr J; de Reijke T; Ng CF; Leung CH; Sanchez-Salas R; Laguna P
    J Urol; 2023 Feb; 209(2):347-353. PubMed ID: 36441776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal therapy for prostate cancer: Making the punishment fit the crime.
    Aoun F; Mjaess G; Abi Tayeh G; Sarkis J; Lilly E; Khalil N; Chebel R; Albisinni S; Roumeguère T; Peltier A
    Prog Urol; 2021 Dec; 31(16):1080-1089. PubMed ID: 34538741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current evidence for focal therapy and partial gland ablation for organ-confined prostate cancer: systematic review of literature published in the last 2 years.
    Kayano PP; Klotz L
    Curr Opin Urol; 2021 Jan; 31(1):49-57. PubMed ID: 33196540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation energies for focal treatment of prostate cancer.
    Lodeizen O; de Bruin M; Eggener S; Crouzet S; Ghai S; Varkarakis I; Katz A; Dominguez-Escrig JL; Pahernik S; de Reijke T; de la Rosette J
    World J Urol; 2019 Mar; 37(3):409-418. PubMed ID: 29943219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal therapy of localized prostate cancer.
    Fujihara A; Ukimura O
    Int J Urol; 2022 Nov; 29(11):1254-1263. PubMed ID: 35996758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible Electroporation for the Ablation of Prostate Cancer.
    Karagiannis A; Varkarakis J
    Curr Urol Rep; 2019 Sep; 20(10):63. PubMed ID: 31478109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological and Functional Outcomes of Patients Undergoing Individualized Partial Gland Cryoablation of the Prostate: A Single-Institution Experience.
    Tan WP; Chang A; Sze C; Polascik TJ
    J Endourol; 2021 Sep; 35(9):1290-1299. PubMed ID: 33559527
    [No Abstract]   [Full Text] [Related]  

  • 20. Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(27):1-118. PubMed ID: 23074405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.